Effects of Lead Exposure on Ferroptosis Pathway
NCT05950386 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2023-07-21
Summary
The aim of this study was to investigate the effects of chronic lead exposure on iron metabolism and the Nrf2-dependent ferroptosis pathway in lead acid battery factory workers
Conditions
- Lead Poisoning
- Neurotoxicity
Interventions
- OTHER
-
Lead exposure
The lead-acid battery factory workers will exposure to lead via Inhalation of lead particles, ingestion of lead-contaminated dust and water.
Sponsors & Collaborators
-
Centers for Disease Control and Prevention
collaborator FED -
Northern Jiangsu People's Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-07-01
- Primary Completion
- 2023-08-10
- Completion
- 2023-09-25
Countries
- China
Study Locations
More Related Trials
-
2-Week Study In People With Nonalcoholic Fatty Liver Disease
NCT03513588 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver Disease
NCT03738358 ·Status: COMPLETED ·Phase: NA
-
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease.
NCT04104282 ·Status: RECRUITING
-
To Evaluate the Clinical Study of CUD005 Injection in Patients With Cirrhosis
NCT06296095 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAR 502 in Healthy Subjects
NCT05203367 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH
NCT05591079 ·Status: COMPLETED ·Phase: PHASE2
-
First Human Dose Trial for a New Medication to Potentially Treat Liver Diseases
NCT05599945 ·Status: COMPLETED ·Phase: PHASE1
-
A Hepatitis B With Hepatic Steatosis Study
NCT02392598 ·Status: UNKNOWN
-
Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients
NCT06863376 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
NCT06613698 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy
NCT06152991 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Role of Obeticholic Acid in the Patients of NAFLD With Raised ALT
NCT03836937 ·Status: COMPLETED ·Phase: NA
-
A Multicenter, Double-blind, Placebo-randomized Controlled Clinical Study on the Treatment of Non-alcoholic Steatohepatitis With Tibetan Drug Langqing Atar
NCT06193629 ·Status: RECRUITING ·Phase: NA
-
Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases
NCT06891365 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase II Clinical Trial of Chiglitazar for NASH
NCT05193916 ·Status: COMPLETED ·Phase: PHASE2
-
Quantifying Hepatic Mitochondrial Fluxes in Humans
NCT05305287 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Tolerability of HepaStem in Patients With Cirrhotic and Pre-cirrhotic NASH Patients
NCT03963921 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Clinical Study to Evaluate CUD005 Injection in Patients with Liver Cirrhosis
NCT06671275 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease
NCT06739486 ·Status: NOT_YET_RECRUITING
-
A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver Cirrhosis
NCT04088058 ·Status: UNKNOWN ·Phase: PHASE2
-
Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients
NCT03850886 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study
NCT06078722 ·Status: UNKNOWN
-
A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
NCT03350165 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Investigate the Anti-oxidant Activity of Heptex in Patients With Apparent Risk Factors of NASH
NCT05343780 ·Status: COMPLETED ·Phase: PHASE2
-
RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic Failure
NCT02331745 ·Status: UNKNOWN ·Phase: PHASE4